Once-daily amoxicillin versus twice-daily penicillin V in group A β-haemolytic streptococcal pharyngitis

Archives of Disease in Childhood

Volumn 93, Issue 6, 2008, Pages 474-478

  Lennon, D R ^a   Farrell, E ^b   Martin, D R ^c   Stewart, J M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Division of Medicine Emergency and Integrated Care   (New Zealand)

^c INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; PENICILLIN V; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIUM ISOLATE; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; ERADICATION THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PATIENT COMPLIANCE; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RHEUMATIC FEVER; SEROTYPE; STREPTOCOCCUS GROUP A; THROAT CULTURE; TREATMENT DURATION; TREATMENT FAILURE; ACUTE DISEASE; COMPARATIVE STUDY; DRUG ADMINISTRATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PRESCHOOL CHILD; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ACUTE DISEASE; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEW ZEALAND; PENICILLIN V; PHARYNGITIS; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 45549088582     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.113506     Document Type: Article

References (46)

1. Anon. Prevention of rheumatic heart disease. Lancet 1982;1:143-4.
2. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005;366:155-68.
3. Denny F, Wannamaker L, Brink W, et al. Prevention of rheumatic fever. Treatment of the preceding streptococcic infection. JAMA 1950;143:151-3.
4. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 2005;5:11.
5. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev 2004;(2):CD000023.
6. Catanzaro FJ, Rammelkamp CH Jr, Chamovitz R. Prevention of rheumatic fever by treatment of streptococcal infections. II. Factors responsible for failures. N Engl J Med 1958;259:53-7.
7. Del Mar C. Managing sore throat: a literature review. II. Do antibiotics confer benefit? Med J Aust 1992;156:644-9.
8. National Heart Foundation of New Zealand. New Zealand guidelines for rheumatic fever. Evidence-based best-practice guidelines on sore throat management. Auckland: National Heart Foundation of New Zealand, 2007 (http.www.heartfoundation.org.nz).
9. Bisno AL, Gerber MA, Gwaltney JM Jr, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002;35:113-25.
10. Hayes CS, Williamson H Jr. Management of group A beta-hemolytic streptococcal pharyngitis. Am Fam Physician 2001;63:1557-64.
11. Dajani AS, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics 1995;96:758-64.
12. Shvartzman P, Tabenkin H, Rosentzwaig A, et al. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ 1993;306:1170-2.
13. Feder Jr HM, Gerber MA, Randolph MF, et al. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics 1999;103:47-51.
14. Clegg HWRA, Dallas SD, Kaplan EL. et al. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial. Pediatr Infect Dis J 2006;25:761-7.
15. Martin DR. Laboratory evaluation of streptococci. In: Stevens D, Kaplan EL, eds. Streptococcal infections: clinical aspects, microbiology and molecular pathogenesis New York: Oxford University Press, 2000:266-79.
16. Peter G. Streptococcal pharyngitis current therapy and criteria for evaluation of new agents Clin Infect Dis 1992;14:S218-23
17. Special Writing Group Guidelines for the diagnosis of rheumatic fever Jones criteria. 1992 update JAMA 1992;268:2069-73
18. Ginsburg CM, McCracken GH Jr, Thomas ML. et al. Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children Pediatrics 1979;64:627-31.
19. Aguilar A, Tinoco JC, Macias M, et al. Clinical and bacteriologic efficacy of amoxycillin b. d. (45 mg/kg/day) versus amoxycillin t.d.s (40 mg/kg/day) in children with group A beta-hemolytic streptococcal tonsillopharyngitis J Chemother 2000;12:396-405.
20. Cohen R, Levy C, Doit C, et al. Six-day amoxicillin vs ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 1996;15:678-82.
21. Curtin-Wirt C, Casey JR, Murray PC, et al. Efficacy of penicillin vs amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis Clin Pediatr (Phila) 2003;42:219-25.
22. Breese BB, Disney FA, Green JL, et al. The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V. Clin Pediatr (Phila) 1977;16:460-3.
23. Breese BB, Disney FA. Talpey WB, et al. Treatment of streptococcal pharyngitis with amoxicillin. J Infect Dis 1974;129(Suppl):S178-80.
24. Gopichand I, Williams GO, Medendorp SV, et al. Randomized, single-blinded comparative study of the efficacy of amoxicillin (40 mg/kg/day) versus standard-dose penicillin V in the treatment of group A streptococcal pharyngitis in children. Clin Pediatr (Phila) 1998;37:341-6.
25. Kearsley NL, Campbell A, Sanderson AA, et al. Comparison of clarithromycin suspension and amoxycillin syrup for the treatment of children with pharyngitis and/or tonsillitis. Br J Clin Pract 1997;51:133- 7.
26. Stillerman M, Isenberg HD, Facklam RR. Treatment of pharyngitis associated with group A streptococcus: comparison of amoxicillin and potassium phenoxymethyl penicillin. J Infect Dis 1974;129(Suppl):S169-77.
27. Markowitz M, Gerber MA, Kaplan EL. Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. Pediatrics 1993;123:679-85.
28. Kaplan EL, Top FH Jr, Dudding BA, et al. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 1971;123:490-501.
29. Lennon D. Rheumatic fever, a preventable disease? In: Martin DR, Tagg JR, eds. Streptococci and streptococcal diseases: entering the new millennium. Porirua: Institute of Environmental Science and Research, 2000:503-12.
30. McAvoy B, Davis P, Raymont A, et al. The Waikato Medical Care (WaiMedCa) survey 1991-1992 [see comment]. N Z Med J 1994;107:388-433.
31. Strasser T, Dondog N, El Kholy A, et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull World Health Organ 1981;59:285-94.
32. Lennon D. Acute rheumatic fever. In: Feigin R, Cherry JD, Demmler GJ, et al, eds. Textbook of pediatric infectious diseases. 5th edn. Baltimore: WB Saunders, 2004:413-26.
33. Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory. Med J Aust 1996;164:146-9.
34. Massell B, Chute C, Walker A, et al. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988;318:280-6.
35. Strasser T. Cost-effective control of rheumatic fever in the community. Health Policy 1985;5:159-64.
36. Breese BB, Disney FA, Talpey WB. Penicillin in streptococcal infections: total dose and frequency of administration. Am J Dis Child 1965;110:125-30.
37. Gerber MA, Randolph MF, DeMeo K, et al. Failure of once-daily penicillin V therapy for streptococcal pharyngitis. Am J Dis Child 1989;143:153-5.
38. Casey JR, Pichichero ME. Metaanalysis of short course antibiotic treatment for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2005;24:909-17.
39. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997;16:680-95.
40. Schaad UB, Kellerhals P, Altwegg M. Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis. Pediatr Infect Dis J 2002;21:304-8.
41. Gerber MA, Tanz RR, Kabat W, et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 1999;104:911-17.
42. Portier H, Chavanet P, Gouyon JB, et al. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. J Antimicrob Chemother 1990;26:79-85.
43. Pichichero ME, Gooch WM, Rodriguez W, et al. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Arch Pediatr Adolesc Med 1994;148:1053-60.
44. Adam D, Hostalek U, Troster K. 5-Day cefixime therapy for bacterial pharyngitis and/ or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. Infection 1995;23(Suppl 2):S83-6
45. Tack KJ, Hedrick JA, Rothstein E, et al. A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group. Arch Pediatr Adolesc Med 1997;151:45-9.
46. Peyramond D, Portier H, Geslin P, et al. 6-Day amoxicillin versus 10-day penicillin V for group A beta-haemolytic streptococcal acute tonsillitis in adults: a French multicentre, open-label, randomized study. The French Study Group Clamorange. Scand J Infect Dis 1996;28:497-501.